1. Home
  2. EDSA vs BGI Comparison

EDSA vs BGI Comparison

Compare EDSA & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • BGI
  • Stock Information
  • Founded
  • EDSA 2015
  • BGI 1879
  • Country
  • EDSA Canada
  • BGI Canada
  • Employees
  • EDSA N/A
  • BGI N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • BGI
  • Sector
  • EDSA Health Care
  • BGI
  • Exchange
  • EDSA Nasdaq
  • BGI Nasdaq
  • Market Cap
  • EDSA 17.2M
  • BGI 15.9M
  • IPO Year
  • EDSA N/A
  • BGI 2005
  • Fundamental
  • Price
  • EDSA $2.39
  • BGI $1.28
  • Analyst Decision
  • EDSA Strong Buy
  • BGI
  • Analyst Count
  • EDSA 2
  • BGI 0
  • Target Price
  • EDSA $13.00
  • BGI N/A
  • AVG Volume (30 Days)
  • EDSA 11.7K
  • BGI 3.3M
  • Earning Date
  • EDSA 08-08-2025
  • BGI 07-25-2025
  • Dividend Yield
  • EDSA N/A
  • BGI N/A
  • EPS Growth
  • EDSA N/A
  • BGI N/A
  • EPS
  • EDSA N/A
  • BGI N/A
  • Revenue
  • EDSA N/A
  • BGI $124,446,731.00
  • Revenue This Year
  • EDSA N/A
  • BGI N/A
  • Revenue Next Year
  • EDSA N/A
  • BGI N/A
  • P/E Ratio
  • EDSA N/A
  • BGI N/A
  • Revenue Growth
  • EDSA N/A
  • BGI N/A
  • 52 Week Low
  • EDSA $1.55
  • BGI $0.56
  • 52 Week High
  • EDSA $5.00
  • BGI $2.38
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 51.55
  • BGI 80.01
  • Support Level
  • EDSA $2.41
  • BGI $0.64
  • Resistance Level
  • EDSA $2.47
  • BGI $1.57
  • Average True Range (ATR)
  • EDSA 0.09
  • BGI 0.13
  • MACD
  • EDSA -0.01
  • BGI 0.05
  • Stochastic Oscillator
  • EDSA 48.15
  • BGI 65.88

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: